Fluorodopa PET scanning in Parkinson's disease.
In summary, FD PET is a valid method for assessing the functional state of the nigrostriatal dopaminergic pathway. It is particularly useful for studies requiring repeated measures such as examinations of the course of a disease and the effect of treatment.
Snow
B J
BJ
Division of Neurology, University of British Columbia, Vancouver, Canada.
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D004298:Dopamine / Q000502:physiology; D006801:Humans; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology / Q000628:therapy; D013378:Substantia Nigra / Q000000981:diagnostic imaging / Q000503:physiopathology; D014055:Tomography, Emission-Computed
C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine; D004298:Dopamine